Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-17 Sale |
2022-08-17 4:23 pm |
Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO |
110,959 | $76 | $8,432,884 | 0 (Direct) |
View |
| 2022-02-09 Sale |
2022-02-11 6:07 pm |
Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO |
2,971 | $36.3 | $107,847 | 334,970 (Direct) |
View |
| 2021-02-09 Sale |
2021-02-11 8:28 pm |
Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO |
60,000 | $137.48 | $8,249,038 | 681,213 (Direct) |
View |
| 2020-05-21 Purchase |
2020-05-26 5:55 pm |
Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO |
4,166 | $60 | $249,960 | 26,872 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-11 Option Award |
2024-06-13 6:03 pm |
N/A N/A |
IOVANCE BIOTHERAPEUTICS INC. | IOVA | Countouriotis Athena Director |
49,303 | $0 | 49,303 (Direct) |
View |
| 2024-05-21 Option Award |
2024-05-23 5:43 pm |
N/A 2034-05-21 |
Passage BIO Inc. | PASG | Countouriotis Athena Director |
47,693 | $0 | 47,693 (Direct) |
View |
| 2024-05-21 Option Award |
2024-05-23 5:14 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Countouriotis Athena Director |
4,720 | $0 | 6,900 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 5:50 pm |
N/A N/A |
IOVANCE BIOTHERAPEUTICS INC. | IOVA | Countouriotis Athena Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-12-27 Option Award |
2023-12-28 1:03 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Countouriotis Athena Director |
2,180 | $0 | 2,180 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 6:22 pm |
N/A N/A |
IOVANCE BIOTHERAPEUTICS INC. | IOVA | Countouriotis Athena Director |
51,955 | $0 | 51,955 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-26 4:22 pm |
N/A 2033-05-24 |
Passage BIO Inc. | PASG | Countouriotis Athena Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 5:03 pm |
N/A N/A |
IOVANCE BIOTHERAPEUTICS INC. | IOVA | Countouriotis Athena Director |
51,204 | $0 | 51,204 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-31 4:20 pm |
N/A 2032-05-25 |
Passage BIO Inc. | PASG | Countouriotis Athena Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 6:07 pm |
N/A 2032-02-08 |
Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO |
287,040 | $0 | 334,970 (Direct) |
View |
| 2021-06-29 Option Award |
2021-07-01 4:17 pm |
N/A 2031-06-29 |
IOVANCE BIOTHERAPEUTICS INC. | IOVA | Countouriotis Athena Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 5:50 pm |
N/A 2031-05-26 |
Passage BIO Inc. | PASG | Countouriotis Athena Director |
16,918 | $0 | 16,918 (Direct) |
View |
| 2021-02-09 Exercise |
2021-02-11 8:28 pm |
N/A 2028-06-05 |
Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO |
60,000 | $0 | 681,213 (Direct) |
View |
| 2021-02-09 Exercise |
2021-02-11 8:28 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO |
60,000 | $3.2 | 681,213 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 5:52 pm |
N/A 2031-02-07 |
Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO |
124,392 | $0 | 151,970 (Direct) |
View |
| 2020-06-08 Option Award |
2020-06-10 8:00 pm |
N/A 2030-06-07 |
IOVANCE BIOTHERAPEUTICS INC. | IOVA | Countouriotis Athena Director |
35,000 | $0 | 35,000 (Direct) |
View |